340B Information
In 1992, Congress extended to safety-net providers the same kind of relief from high drug costs that Congress provided to the Medicaid program with the Medicaid rebate law. In particular, Congress enacted Section 340B of the Public Health Service Act (created under Section 602 of the Veterans Health Care Act of 1992). Section 340B requires pharmaceutical manufacturers to enter into an agreement, called a pharmaceutical pricing agreement (PPA), with the HHS Secretary. Under the PPA, the manufacturer agrees to provide front-end discounts on covered outpatient drugs purchased by specified providers, called "covered entities," that serve the nation's most vulnerable patient populations. According to congressional report language, the purpose of the 340B program is to enable covered entities “to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services."
Resources
- Alzheimer's Disease
-
Chronic Disease Prevention Section
- Chronic Disease Data
- Evaluation
- For Healthcare Providers
- Chronic Disease University
- For Health Departments
- Asthma
- Community Health Workers
- Worksite Health
- Cancer Prevention and Control
- Cardio Metabolic Syndrome
- Diabetes
- Heart Disease
- Nutrition and Physical Activity
- School Health
- Sexual Violence Prevention
- Adolescent Health and Youth Development
- SNAP-Ed
- Tobacco
- HIV/AIDS
- Injury Prevention Program
- Nursing
- Opioid and Substance Misuse Response
- Pharmacy
- Refugee Health Program
- STDs
- Tuberculosis (TB) Prevention and Control
- Get Alerts